This activity has expired. Credit is no longer available.
This activity was supported by an educational grant from Celgene Corporation
Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
Patricia Mangan, RN, MSN, CRNP
Abramson Cancer Center
Edward A. Stadtmauer, MD
Perelman School of Medicine, Hospital of the University of Pennsylvania
Discover the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerging toxicities, and future directions in the use of this novel therapy.
|
|
These activities, certified for CME/CE/CPE credit, are jointly provided by
  |
in collaboration with
  |